Skip to main content
. 2022 Feb 18;37(7):S457–S464. doi: 10.1016/j.arth.2021.10.023

Table 1.

Demographic Comparison of Patients Diagnosed With COVID-19 Within 3 mo of TJA and Controls Not Diagnosed With COVID, Unmatched and Matched Data.

Matched
Unmatched
TJA, COVID+, n (%) TJA, No COVID, n (%) P-Value TJA, COVID+, n (%) TJA, No COVID, n (%) P-Value
Total 239 713 Reference 312 5368 Reference
THA 132 55.2% 395 55.4% 1.000 194 62.2% 2209 41.2% <.001a
Demographics
 Age, mean, SD 72.9 8.4 72.6 8.3% 1.000 73.0 9.7% 66.4 9.9% <.001a
 Gender 1.000 .711
 Male 88 36.8% 261 36.6% 125 40.1% 2085 38.8%
 Female 151 63.2% 452 63.4% 187 59.9% 3283 61.2%
 Plan .317 .036a
 Commercial 136 57.0% 391 54.9% 169 54.2% 3361 62.6%
 Medicaid 15 6.2% 32 4.5% 18 5.8% 259 4.8%
 Medicare 80 33.5% 277 38.9% 116 37.2% 1636 30.5%
Comorbidities
 Hypertension 173 72.4% 502 70.4% .617 237 76.0% 3558 66.3% <.001a
 COPD 33 13.8% 93 13.0% .848 55 17.6% 854 15.9% .468
 CHF 3 1.3% 3 0.4% .348 5 1.6% 198 3.7% .076
 Smoking 5 2.1% 11 1.5% .779 7 2.2% 300 5.6% .016
 CKD 43 18.0% 130 18.2% 1.000 79 25.3% 639 11.9% <.001a
 Diabetes 76 31.8% 232 32.5% .895 109 34.9% 1731 32.2% .355
 Obesity 59 24.7% 161 22.6% .562 76 24.4% 1259 23.5% .766
 Depression 54 22.6% 123 17.3% .082 76 24.4% 804 15.0% <.001a
 Hypothyroidism 38 15.9% 107 15.0% .819 50 16.0% 817 15.2% .761
 PVD 29 12.1% 109 15.3% .275 57 18.3% 639 11.9% .001a
 Coagulopathy 11 4.6% 39 5.5% .724 21 6.7% 229 4.3% .055a
 Cancer 46 19.2% 126 17.7% .652 75 24.0% 778 14.5% <.001a
 Iron deficiency anemia 32 13.2% 62 8.7% .058 50 16.0% 399 7.4% <.001a
 Liver disease 12 5.0% 36 5.0% 1.000 19 6.1% 267 5.0% .457
 Alcohol use 9 3.8% 14 2.0% .185 12 3.8% 124 2.3% .125

TJA, total joint arthroplasty; THA, total hip arthroplasty; SD, standard deviation; COPD, chronic obstructive pulmonary disease; CHF, congestive heart failure; CKD, chronic kidney disease; PVD, peripheral vascular disease.

a

Indicates statistical significance of P < .05.